PVRIG

PVRIG

PVRIG Informations sur la molécule

Molecule Name
Transmembrane protein PVRIG
Alias de la molécule
C7orf15,C7orf15MGC138295,CD112R,MGC104322,MGC138297,MGC2463,PVRIG,CD112 receptor
Drug Development Progress
Nombre de médicaments cliniques7
Nombre de médicaments commercialisés0
Phase de R&D la plus avancéePhase 2 Clinical
Alias de la cible
PVRIG,PVR Related Immunoglobulin Domain Containing,CD112 Receptor,Poliovirus Receptor-Related Immunoglobulin Domain-Containing Protein,Poliovirus Receptor Related Immunoglobulin Domain Containing,Nectin-2 Receptor,C7orf15,CD112R,Transmembrane Protein PVRIG,MGC2463
Contexte de la molécule
Human PVRIG (poliovirus receptor related immunoglobulin domain-containing protein), also known as CD112 receptor (CD112R), is an approximately 34 kDa single transmembrane protein in the poliovirus receptor-like protein (PVR) family. The CD112R gene encodes a putative single transmembrane protein, which is composed of a single extracellular IgV domain, one transmembrane domain, and a long intracellular domain. Notably, the intracellular domain of phatases. The extracellular domain sequence of human and mouse CD112R have 65.3% similarity. CD112R may act as a coinhibitory receptor that suppresses T-cell receptor-mediated signals.

PVRIG Liste de produits

Species
  • Human(5)
  • Mouse(4)
  • Cynomolgus(2)
Tag
  • His Tag(4)
  • Fc Tag(3)
  • His Tag & Avi Tag(2)
  • Fc Tag & Avi Tag(1)
  • Mouse IgG Fc Tag(1)
Host
  • HEK293(11)
Conjugate
  • Unconjugated(8)
  • Biotin-labeled(3)
Grade
  • RUO(11)
Low Endotoxin
  • Yes(2)
  • No(9)
MoleculeCat. No.Product NameEspèceHostStructurePurityActivitySize&PriceAdd to Cart
PVRIG
Human PVRIG Protein, Mouse IgG2a Fc Tag, low endotoxin (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISABLI

$360.00

100ug
PVRIG
Human PVRIG Protein, Fc Tag, low endotoxin (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$360.00

100ug
PVRIG
HOTAvitag
PVG-H82E3
Biotinylated Human PVRIG Protein, His,Avitag™
Human
HEK293
SDS-PAGE
ELISA

$360.00

25ug
PVRIG
Human PVRIG Protein, His Tag
Human
HEK293
SDS-PAGE
ELISABLI

$360.00

100ug
PVRIG
Cynomolgus PVRIG Protein, Fc Tag (MALS verified)
Cynomolgus
HEK293
MALSSDS-PAGE
ELISABLI

$390.00

100ug
PVRIG
Cynomolgus PVRIG Protein, His Tag (MALS verified)
Cynomolgus
HEK293
MALSSDS-PAGE
ELISA

$360.00

100ug
PVRIG
Human PVRIG Protein, His Tag (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$360.00

100ug
PVRIG
Mouse PVRIG Protein, Fc Tag (MALS verified)
Mouse
HEK293
MALSSDS-PAGE

$390.00

100ug
PVRIG
Mouse PVRIG Protein, His Tag (MALS verified)
Mouse
HEK293
MALSSDS-PAGE

$390.00

100ug
PVRIG
Avitag
PVG-M82E3
Biotinylated Mouse PVRIG Protein, His,Avitag™
Mouse
HEK293
SDS-PAGE

$360.00

25ug
You Have Viewed 1-10 Of 11 Results
  • 1
  • 2

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity

Plateforme de commerce de projets d'anticorps

Nom du projetPhase du projetType de moléculeSource de moléculeDomain thérapeutiqueIndication
TIGIT&PVRIG BsAb - 01PCCMonoclonalHumanized MouseSolid TumorSolid tumor
Phase du projet
PCC
Type de molécule
Monoclonal
Source de molécule
Humanized Mouse
Domain thérapeutique
Solid Tumor
Indication
Solid tumor
Resources

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
COM-701COM-701Phase 2 ClinicalCompugen Ltd
Breast Neoplasms; Colorectal Neoplasms; Endometrial Neoplasms; Head and Neck Neoplasms; Lung Neoplasms; Neoplasms; Ovarian Neoplasms; Solid tumours; Triple Negative Breast Neoplasms
Details
PM-1009PM1009Phase 2 Clinical
Carcinoma, Hepatocellular; Liver Neoplasms; Lung Neoplasms; Neoplasms; Solid tumours
Details
SIM-0348SIM-0348Phase 1 ClinicalSimcere Pharmaceutical Group Ltd
Neoplasms; Solid tumours
Details
GSK-4381562SRF-813; GSK-4381562; GSK-4381562A; GSK4381562A; GSK’562Phase 1 ClinicalSurface Oncology Inc
Neoplasms; Solid tumours
Details
NM1FNM1F; TGI-2Phase 1 ClinicalHefei TG ImmunoPharma Co Ltd
Colorectal Neoplasms; Melanoma; Ovarian Neoplasms; Solid tumours; Triple Negative Breast Neoplasms
Details
SHR-2002SHR-2002Phase 1 ClinicalShanghai Hengrui Pharmaceutical Co Ltd, Suzhou Suncadia Biopharmaceuticals Co Ltd
Neoplasms
Details
JS-009JS009; TAB009; JS-009Phase 1 ClinicalShanghai Junshi Biosciences Co Ltd
Neoplasms; Solid tumours
Details
Customer Reviews